Assay Corporate Finance is pleased to announce that it successfully advised the shareholders of Government Grants and Tax Consultants Ltd (“GGTC”) in arranging a significant minority investment in GGTC and its wider Group from private equity investors, Foresight Group (“Foresight”).

The investment will support the growth of the business and aid the development of other companies in the Group.

Founded in 2006 by John Penn, Chairman, and Jeremy Tear, Managing Director, GGTC provides research and development tax credit support to UK-based SMEs. Companies in the wider Group including, Capital Allowances Specialist Ltd and Patent Box Consultants Ltd, also provide support services to UK SMEs looking to gain access to government tax incentives which have proved an important enabler to growth.

In addition to supporting the continued growth of GGTC across the UK, Foresight’s investment will assist the Group as it looks to diversify its product and service offering, providing further much needed support to UK based SMEs. GGTC currently has two offices, one based in St Albans and one in Hertford.

Jeremy Tear, commented:

“Assay Advisory and its corporate finance arm, Assay Corporate Finance worked with us for over 18 months doing all the ground work helping us find a future for the company.  Assay did a lot more for us than just their corporate finance job and their support has been fantastic.”

Mike Simson, Assay Advisory Partner commented:

“The GGTC project is a great example of how our consultants worked with the client preparing the business for exit which then lead onto a transaction initiated and advised by our corporate finance team.”

December 2015

About Assay Advisory

Assay combines extensive transaction experience with an analytical and quantitative framework in order to transfer its knowledge to business owners.

Assay’s unique service offering blends the organisational transformation elements of consulting with the strategic elements of corporate finance. They specialise in getting investors or acquirers to value their business from a strategic perspective by focusing on the valuation multiple, instead of treating it as a simple financial transaction.

Assay comprises 12 consulting partners and 5 transaction partners based in the UK, USA, Australia and Benelux.